Summary
- Windtree (WINT) announced it plans to raise up to $200 million to invest in Binance Coin (BNB).
- Windtree stated it has already signed a $60 million stock purchase agreement with Build and Build Corp.
- Windtree explained that as the first Nasdaq-listed company to reserve BNB tokens, it can offer institutional investors an opportunity to access the Binance ecosystem.
Windtree Therapeutics (WINT), a Nasdaq-listed biotechnology company, has announced plans to raise up to $200 million to invest in Binance Coin (BNB).
According to GlobeNewswire on the 16th (local time), Windtree stated in a press release that it "plans to raise up to $200 million to reserve Binance Coin (BNB)" and has already "signed a stock purchase agreement worth $60 million with Build and Build Corp."
Windtree further commented, "We are the first Nasdaq-listed company to reserve BNB tokens," adding, "We can offer institutional investors seeking access to the Binance ecosystem an opportunity."
Son Min
sonmin@bloomingbit.ioHello I’m Son Min, a journalist at BloomingBit
![[Exclusive] Toss Reviews Acquisition of Overseas Crypto Exchange… In Talks With US Institutional Platform](https://media.bloomingbit.io/PROD/news/148973fc-2c49-4ab4-8934-c7e9d49c847b.webp?w=250)
![[Exclusive] Toss sets up a dedicated blockchain unit…begins building digital-asset infrastructure](https://media.bloomingbit.io/PROD/news/76d3ff2d-0b0f-402b-b842-90eeeb7f183d.webp?w=250)